A Safety Study of SGN-CD47M in Patients With Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Soft Tissue Sarcoma|Colorectal Cancer|Head and Neck Squamous Cell Carcinoma|Non-small Cell Lung Carcinoma|Breast Carcinoma|Ovarian Carcinoma|Exocrine Pancreatic Carcinoma|Gastric Carcinoma|Melanoma
Interventions: DRUG: SGN-CD47M
Sponsor: Seagen Inc.